PRME
Prime Medicine
$3.01
+$0.06 (+2.03%)Jul 27, 2026
Key metrics
The numbers that frame PRME today
- Market cap
- $543.66M
- P/E (TTM)
- -2.7
- EV / FCF
- -3.7
- Gross margin
- 100%
- EV / Sales
- 143.9
- ROIC
- -60.1%
- Div yield
- 0%
- Debt / equity
- 1.5
- 52wk Low
- $2.67
- 52wk High
- $6.94
Growth
Revenue and earnings trend for PRME
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PRME
Is Prime Medicine a good buy?
No. Prime Medicine has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Prime Medicine is selling at a very high price.
What is the market capitalization of PRME?
Prime Medicine's market capitalization is $543.66M.
What is the P/E ratio for PRME stock?
Prime Medicine's current P/E ratio is -2.7.
What is the 52-week high for PRME stock?
The 52-week high for Prime Medicine is $6.94. The current close of $3.01 is 56.6% below that high.
What is the 52-week low for PRME stock?
The 52-week low for Prime Medicine is $2.67. The current close of $3.01 is 12.7% above that low.
Does PRME stock pay dividends?
Prime Medicine does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PRME?
Prime Medicine's Debt / Equity ratio is 1.49.